Literature DB >> 19844099

Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study.

R F Gottesman1, C Cummiskey, L Chambless, K K Wu, N Aleksic, A R Folsom, A R Sharrett.   

Abstract

BACKGROUND: Previous data are conflicting as to whether imbalance between hemostatic factors is associated with clinical strokes. We evaluated the association between hemostatic factor levels and subclinical lacunar infarcts in a nested sample from a subset of the Atherosclerosis Risk in Communities (ARIC) cohort.
METHODS: 196 cases without clinical strokes had lacunar infarcts by MRI, and 214 controls without radiographic infarcts were frequency-matched by age group and sex. Logistic regression models were fitted to assess the association between levels of hemostatic markers and case status.
RESULTS: In age-, race- and sex-adjusted models, von Willebrand factor (vWF) and D-dimer were positively associated with case status, with odds ratios for the highest vs. lowest tertile of 2.0 (95% CI 1.2-3.6) for vWF and 1.76 (95% CI 1.02-3.0) for D-dimer. Plasminogen had nonsignificant inverse associations with presence of silent lacunar infarcts.
CONCLUSIONS: vWF and D-dimer were positively associated, and plasminogen was nonsignificantly inversely associated with subclinical radiographic infarct. Further studies on the role of these hemostatic factors in the development of silent lacunar infarcts may help elucidate the mechanisms behind this injury and may even point to potential targets for future intervention. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844099      PMCID: PMC2914353          DOI: 10.1159/000247603

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  25 in total

1.  Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  A R Folsom; W D Rosamond; E Shahar; L S Cooper; N Aleksic; F J Nieto; M L Rasmussen; K K Wu
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

2.  Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Folsom; N Aleksic; E Park; V Salomaa; H Juneja; K K Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

3.  Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study.

Authors:  M W Knuiman; A R Folsom; L E Chambless; D Liao; K K Wu
Journal:  Neuroepidemiology       Date:  2001-05       Impact factor: 3.282

4.  LACUNES: SMALL, DEEP CEREBRAL INFARCTS.

Authors:  C M FISHER
Journal:  Neurology       Date:  1965-08       Impact factor: 9.910

5.  Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.

Authors:  A Lindgren; C Lindoff; B Norrving; B Astedt; B B Johansson
Journal:  Stroke       Date:  1996-06       Impact factor: 7.914

6.  Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort.

Authors:  David S Knopman; Thomas H Mosley; Diane J Catellier; A Richey Sharrett
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

7.  Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects.

Authors:  K Kario; T Matsuo; H Kobayashi; S Hoshide; K Shimada
Journal:  J Am Coll Cardiol       Date:  2001-03-01       Impact factor: 24.094

8.  Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.

Authors:  Ann Smith; Chris Patterson; John Yarnell; Ann Rumley; Yoav Ben-Shlomo; Gordon Lowe
Journal:  Circulation       Date:  2005-11-15       Impact factor: 29.690

9.  Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.

Authors:  F B Smith; A J Lee; F G Fowkes; J F Price; A Rumley; G D Lowe
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

10.  Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study.

Authors:  V Salomaa; C Matei; N Aleksic; L Sansores-Garcia; A R Folsom; H Juneja; L E Chambless; K K Wu
Journal:  Lancet       Date:  1999-05-22       Impact factor: 79.321

View more
  10 in total

1.  Chronic Systemic Immune Dysfunction in African-Americans with Small Vessel-Type Ischemic Stroke.

Authors:  Candice M Brown; Cheryl D Bushnell; Gregory P Samsa; Larry B Goldstein; Carol A Colton
Journal:  Transl Stroke Res       Date:  2015-09-15       Impact factor: 6.829

2.  Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.

Authors:  Marco Campos; Wei Sun; Fuli Yu; Maja Barbalic; Weihong Tang; Lloyd E Chambless; Kenneth K Wu; Christie Ballantyne; Aaron R Folsom; Eric Boerwinkle; Jing-Fei Dong
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

Review 3.  Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability.

Authors:  A Vilar-Bergua; I Riba-Llena; C Nafría; A Bustamante; V Llombart; P Delgado; J Montaner
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

4.  Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study.

Authors:  Aleksandra Pikula; Alexa S Beiser; Charles DeCarli; Jayandra J Himali; Stephanie Debette; Rhoda Au; Jacob Selhub; Geoffrey H Toffler; Thomas J Wang; James B Meigs; Margaret Kelly-Hayes; Carlos S Kase; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri
Journal:  Circulation       Date:  2012-03-28       Impact factor: 29.690

Review 5.  Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review.

Authors:  Anna Poggesi; Marco Pasi; Francesca Pescini; Leonardo Pantoni; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

6.  Significance of plasma D-dimer in relation to the severity of atherosclerosis among patients evaluated by non-invasive indices of cardio-ankle vascular index and carotid intima-media thickness.

Authors:  Shigeru Hayashi
Journal:  Int J Hematol       Date:  2010-06-18       Impact factor: 2.490

7.  A cluster of blood-based protein biomarkers reflecting coagulation relates to the burden of cerebral small vessel disease.

Authors:  Sanne Kuipers; L Malin Overmars; Bram van Es; Jeroen de Bresser; Esther E Bron; Imo E Hoefer; L Jaap Kappelle; Charlotte E Teunissen; Geert Jan Biessels; Saskia Haitjema
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-27       Impact factor: 6.960

8.  Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes.

Authors:  Q Y Wang; J Song; R A Gibbs; E Boerwinkle; J F Dong; F L Yu
Journal:  J Thromb Haemost       Date:  2013-02       Impact factor: 5.824

9.  Air quality improvement during 2010 Asian games on blood coagulability in COPD patients.

Authors:  Zili Zhang; Jian Wang; Meihua Guo; Mingmei Xiong; Qipeng Zhou; Defu Li; Jiaze Shu; Wenju Lu; Dejun Sun
Journal:  Environ Sci Pollut Res Int       Date:  2015-12-09       Impact factor: 4.223

10.  Plasma d-Dimer and Incident Ischemic Stroke and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study.

Authors:  Aaron R Folsom; Rebecca F Gottesman; Duke Appiah; Eyal Shahar; Thomas H Mosley
Journal:  Stroke       Date:  2015-11-10       Impact factor: 7.914

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.